Property:Inclusion criteria
This is a property of type Text.
V
Patients with carcinomas in the floor of the mouth, who underwent preoperative radiotherapy +
Vitale et al. (2020): ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy +
Histologically confirmed diagnosis of cancer, at least 18 years of age, oxaliplatin chemotherapy, and adequate hematologic parameters to allow chemotherapy +
W
Walsh et al. (2010): Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma +
Patients with newly diagnosed head and neck squamous cell carcinoma who were being scheduled for surgery +
Watanabe et al. (2010): Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer +
Patients with head and neck cancer who underwent radiotherapy or radiochemotherapy +
Williams et al. (1996): Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity +
? +
Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente +
Patients with untreated inoperable bronchopulmonary carcinomas of various entities +
Wyatt et al. (2012): Health-Related Quality-of-Life Outcomes: A Reflexology Trial With Patients With Advanced-Stage Breast Cancer +
21 years or older; having a diagnosis of stage III or IV breast cancer, metastasis, or recurrence; being able to perform basic activities of daily living; being cognitively intact and without a documented diagnosis of mental illness; being able to speak and understand English; having access to a telephone; being able to hear normal conversation; receiving chemotherapy at intake into the study; and having a score of 11 or lower on the Palliative Prognostic Score (Pirovano et al., 1999), which indicates a 30% probability of having a life expectancy of at least three months +
Wyatt et al. (2017): A Randomized Clinical Trial of Caregiver-Delivered Reflexology for Symptom Management During Breast Cancer Treatment +
Patient inclusion criteria were: 1) age >21, 2) stage III or IV breast cancer, 3) able to perform basic activities of daily living, 4) undergoing chemotherapy, targeted or hormonal therapy at the time of enrollment, 5) able to speak and understand English, 6) having access to a telephone, 7) able to hear normal conversation, and 8) cognitively oriented to time, place, and person (determined via recruiter).
Friend/family caregiver inclusion criteria were 1) age >18, 2) able and willing to provide at least one 30-minute protocol session per week for four consecutive weeks, 3) able to speak and understand English, 4) access to a telephone, 5) able to hearnormal conversation, and 6) cognitively oriented to time, place, and person (determined via recruiter). +
Y
Yap et al. (2017): Predictors of hand-foot syndrome and pyridoxine for prevention of capecitabine-induced hand-foot syndrome: a randomized clinical trial +
Patients scheduled to receive single-agent capecitabine chemotherapy for breast, colorectal, and other cancers +
Patients with histologic diagnosis of breast cancer, history of receiving at least one chemotherapy injection, receiving single-day cycles of chemotherapy (each cycle separated from next by ≥ 2 weeks); experiencing vomiting in previous sessions, and having normal values of hematologic and biomedical laboratory parameters. +
Z
Zalat et al. (2020): Evaluation of the cardioprotective effects of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy +
Cancer patients receiving anthracycline chemotherapy in their protocol alone (without any cardioprotective agent), aged 20-60 years +
Zick et al. (2008): Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting +
Patients who were scheduled to have a single-day chemotherapy regime and to receive a 5-HT3 receptor antagonist antiemetic and/or the antiemetic aprepitant.
Patients with histologically confirmed diagnosis of cancer currently being treated with chemotherapy.
Patients must also have received at least one previous chemotherapy treatment with the same chemotherapeutic agent and have experienced nausea or vomiting of any severity as a result of that treatment. +
Ö
Özdelikara et al. (2017): The Effect of Reflexology on Chemotherapy-induced Nausea, Vomiting, and Fatigue in Breast Cancer Patients +
Being older than 18, knowing the diagnosis of the disease, receiving no radiotherapy, receiving an epirubicin and cyclophosphamide, having received no reflexology therapy before, literate in Turkish, having no hemorrhage, epilepsy, or fever, having no paraplegia or thrombosis, having no gall-kidney stones, having no leg varicosis and foot disease (open wound or fracture on foot), having no diagnosis of psychiatric disorder or dementia, having accepted to participate in the study. +
Özdelikara et al. (2017): The effect of reflexology on the quality of life with breast cancer patients +
Being older than 18, knowing the diagnosis of the disease, receiving no radiotherapy, receiving a epirubicin and cyclophosphamide, having received no reflexology therapy before, being literate in Turkish +